References
- Mathews V, George B, Lakshmi K M, Viswabandya A, Bajel A, Balasubramanian P, et al. Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity. Blood 2006; 107: 2627–2632
- Raffoux E, Rousselot P, Poupon J, Daniel M T, Cassinat B, Delarue R, et al. Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia. J Clin Oncol 2003; 21: 2326–2334
- Begaud B, Evreux J, Jouglard J, Lagier G. Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France. Therapie 1985; 42: 111–118
- Hamard H, Desbordes J M. [Iatrogenic pathology of the optic nerve]. Ann Ther Clin Ophtalmol 1982; 33: 185–202
- Witzel D A, Smith E L, Beerwinkle K R, Johnson J H. Arsanilic acid-induced blindness in swine: electroretinographic and visually evoked responses. Am J Vet Res 1976; 37: 521–524
- Kamijo Y, Soma K, Asari Y, Ohwada T. Survival after massive arsenic poisoning self-treated by high fluid intake. J Toxicol Clin Toxicol 1998; 36: 27–29
- Otto D, He L, Xia Y, Li Y, Wu K, Ning Z, et al. Neurosensory effects of chronic exposure to arsenic via drinking water in Inner Mongolia. II. Vibrotactile and visual function. J Water Health 2006; 4: 39–48
- Vahidnia A, Romijn F, Tiller M, van der Voet G B, de Wolff F A. Arsenic-induced toxicity: effect on protein composition in sciatic nerve. Hum Exp Toxicol 2006; 25: 667–674